Literature DB >> 1591573

Blunted prolactin responses to d-fenfluramine in sociopathy. Evidence for subsensitivity of central serotonergic function.

V O'Keane1, E Moloney, H O'Neill, A O'Connor, C Smith, T G Dinan.   

Abstract

Using a neuroendocrine probe we studied nine male offenders in a forensic hospital, convicted of murder, with a diagnosis of antisocial personality disorder, who had been behaviourally 'quiescent' for varying periods and who had not recently been abusing drugs. Nine healthy age-matched men also participated. All subjects received 30 mg d-fenfluramine (d-FEN), a 5-HT releasing agent, orally, after an overnight fast, and serial samples for prolactin estimation were taken hourly for five hours. Responses were significantly impaired in the patients, suggesting a subsensitivity of certain 5-HT systems in antisocial personality disorder, regardless of recent or ongoing behavioural disturbance.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1591573     DOI: 10.1192/bjp.160.5.643

Source DB:  PubMed          Journal:  Br J Psychiatry        ISSN: 0007-1250            Impact factor:   9.319


  21 in total

Review 1.  Stimulation-induced behavioral inhibition: a new model for understanding physical violence.

Authors:  A R Mawson
Journal:  Integr Physiol Behav Sci       Date:  1999 Jul-Sep

2.  Tryptophan-hydroxylase 2 haplotype association with borderline personality disorder and aggression in a sample of patients with personality disorders and healthy controls.

Authors:  M Mercedes Perez-Rodriguez; Shauna Weinstein; Antonia S New; Laura Bevilacqua; Qiaoping Yuan; Zhifeng Zhou; Colin Hodgkinson; Marianne Goodman; Harold W Koenigsberg; David Goldman; Larry J Siever
Journal:  J Psychiatr Res       Date:  2010-05-06       Impact factor: 4.791

3.  Relationship of disinhibition and aggression to blunted prolactin response to meta-chlorophenylpiperazine in cocaine-dependent patients.

Authors:  Ashwin A Patkar; Paolo Mannelli; Kathleen Peindl; Kevin P Hill; Raman Gopalakrishnan; Wade H Berrettini
Journal:  Psychopharmacology (Berl)       Date:  2006-01-17       Impact factor: 4.530

4.  Associations among central nervous system serotonergic function and neuroticism are moderated by gender.

Authors:  Beverly H Brummett; Stephen H Boyle; Cynthia M Kuhn; Ilene C Siegler; Redford B Williams
Journal:  Biol Psychol       Date:  2008-03-12       Impact factor: 3.251

5.  The effect of tryptophan depletion and enhancement on subjective and behavioural aggression in normal male subjects.

Authors:  A J Cleare; A J Bond
Journal:  Psychopharmacology (Berl)       Date:  1995-03       Impact factor: 4.530

Review 6.  Post-traumatic stress disorder and serotonin: new directions for research and treatment.

Authors:  L L Davis; A Suris; M T Lambert; C Heimberg; F Petty
Journal:  J Psychiatry Neurosci       Date:  1997-11       Impact factor: 6.186

Review 7.  Serotonergic function, two-mode models of self-regulation, and vulnerability to depression: what depression has in common with impulsive aggression.

Authors:  Charles S Carver; Sheri L Johnson; Jutta Joormann
Journal:  Psychol Bull       Date:  2008-11       Impact factor: 17.737

8.  5-HTTLPR and gender moderate changes in negative affect responses to tryptophan infusion.

Authors:  Beverly H Brummett; Christopher L Muller; Ann L Collins; Stephen H Boyle; Cynthia M Kuhn; Ilene C Siegler; Redford B Williams; Allison Ashley-Koch
Journal:  Behav Genet       Date:  2008-07-26       Impact factor: 2.805

9.  Aggression, suicidality, and intermittent explosive disorder: serotonergic correlates in personality disorder and healthy control subjects.

Authors:  Emil F Coccaro; Royce Lee; Richard J Kavoussi
Journal:  Neuropsychopharmacology       Date:  2010-01       Impact factor: 7.853

10.  Gene x environment interactions for ADHD: synergistic effect of 5HTTLPR genotype and youth appraisals of inter-parental conflict.

Authors:  Molly Nikolas; Karen Friderici; Irwin Waldman; Katherine Jernigan; Joel T Nigg
Journal:  Behav Brain Funct       Date:  2010-04-16       Impact factor: 3.759

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.